La Jolla Pharmaceutical Co (LJPC)

[TradingCharts]

Upcoming FDA panel decision on Corvue next week

sudip <[e-mail]>

FDA Panel to review this Biotech company's stress agent drug on July
28th. If they get a favorable backing by the panel, the chances of
approval by the FDA will increase significantly. If the drug gets
approved by the FDA, it is estimated to achieve Peak sales of $350
million. To read about our expectation on the Panel decision, the
company, the drug, the disease and the potential impact of this FDA
Panel decision next week, get the FREE report at our website :
NEWBIOMEDICINE.COM
http://finance.google.com/group/google.finance.658229/msg/f037cd93c6381a1a?dmode=print